DCI
Data Collective IV Portfolio holdings
AUM
$130M
This Quarter Return
-15.85%
1 Year Return
+250.71%
3 Year Return
+278.3%
5 Year Return
–
10 Year Return
–
AUM
$741M
AUM Growth
–
Cap. Flow
+$741M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EMBK
Embark Technology, Inc. Common Stock
EMBK
|
$553M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$102M |
| 3 |
Evolv Technologies
EVLV
|
$47.3M |
| 4 |
Rocket Lab Corporation Common Stock
RKLB
|
$36M |
| 5 |
MindMed
MNMD
|
$2.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 74.67% |
| 2 | Healthcare | 14.09% |
| 3 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMBK
1
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $553M | 74.67% |
+3,186,008
| New | +$553M |
|
|
2
Recursion Pharmaceuticals
RXRX
$2.02B
| $102M | 13.74% |
+5,941,120
| New | +$102M |
|
|
3
Evolv Technologies
EVLV
$1.37B
| $47.3M | 6.38% |
+10,601,281
| New | +$47.3M |
|
|
4
Rocket Lab Corporation Common Stock
RKLB
$21B
| $36M | 4.86% |
+2,929,350
| New | +$36M |
|
|
5
MindMed
MNMD
$689M
| $2.6M | 0.35% |
+100,350
| New | +$2.6M |
|